Michael Stevens, PhD

Dr. Stevens has been continually funded by the National Institutes of Health since shortly after he received his Ph.D. in Clinical Psychology from the University of Connecticut in 1999. His NRSA-funded postdoctoral work at the University of Connecticut Health Center focused on neuropsychological and neurobiological study of adolescent risk factors for addictions. After joining the UCHC faculty as an assistant professor and starting adolescent-related clinical and research programs, Dr. Stevens left in 2002 to help develop the just-founded Olin Neuropsychiatry Research Center. Here, Dr. Stevens received a K23 Career Development award from the NIMH to provide him opportunity to gain expertise in fMRI and EEG methods. He received his academic appointment in the Yale Department of Psychiatry in 2003, was promoted to Adjunct Associate Professor in 2009, and Full Professor in 2017. During this time, he has been the Principal Investigator or a co-investigator on dozens of R01-level NIH grants that use neuroimaging, EEG, neurocognitive, and genetic methods to better understand a variety of different neuropsychiatric disorders. These include ADHD and other disruptive behavior disorders of childhood, Major Depressive Disorder and Bipolar Illness, Autism, psychosis, TBI, and recently both alcohol-related addiction as well as the effects of cannabis on the brain. Much of this research work focuses on the developmental period starting at puberty until early adulthood, and incorporates both concepts and methodology that examines distributed neural networks in the brain. Most recently, Dr. Stevens has become keenly interested in using neuroimaging tools to accelerate development of novel, non-pharmacological clinical interventions such as cognitive training, rTMS and tDCS